TargetCancer announces new grants!
Click to Donate
Click here if you are having trouble with the above donation button.
TargetCancer promotes the development of lifesaving treatment protocols for rare cancers. TargetCancer directly supports initiatives at the forefront of cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients.
We are very proud to announce over $70,000 in new rare cancer research funding!
• $32,000 to create the TargetCancer Cholangiocarcinoma Cell Line Bank at Massachusetts General Hospital, a unique program to collect and preserve critical cell line samples.
• $20,000 to continue our past support of Dr. Nabeel Bardeesy's groundbreaking molecular bile duct cancer research at the Massachusetts General Hospital Cancer Center. Research funded directly by this grant was recently published in the journal Cancer Research.
• $10,000 to fund Dr. Adam Bass' genomic study of esophageal cancer at the Dana-Farber Cancer Institute.
• $8,300 to fund the second year of our three year commitment to the TargetCancer Medical Student Research Fund at Harvard Medical School.
Please click here for much more information on all of these exciting grants!
TargetCancer's 2nd Annual Fundraiser a success!
On November 3, 2011, over three hundred people joined us in Boston to raise money for rare cancer research.
We're proud to announce that over $80,000 was raised over the course of the cocktail reception, auction, and concert!
Open Pictures in new window.
